Michael Lee Milligan - Title: Chief Financial Officer & Principal Accounting Officer at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Title: Chief Financial Officer & Principal Accounting Officer
Issuer Symbol
NMRA on Nasdaq
All Insider Reports
All Insider Reports

Michael Lee Milligan - trading volume in the past year for Neumora Therapeutics, Inc.

Holdings reported by Michael Lee Milligan for Neumora Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21,034 $74,986 $3.56 17 Feb 2026 Direct
Stock Option (Right to Buy) 350,000 08 Jan 2026 Direct Common Stock

Transactions reported by Michael Lee Milligan for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.